Your browser doesn't support javascript.
loading
PD-1 Immune Checkpoint Inhibitor Therapy Malignant Tumor Based on Monotherapy and Combined Treatment Research.
Zhang, Yu; Mou, Guang-Ze; Li, Tian-Zhu; Xu, Wan-Ting; Zhang, Tong; Xue, Hui; Zuo, Wen-Bo; Li, Yan-Nan; Luo, Ying-Hua; Jin, Cheng-Hao.
Afiliação
  • Zhang Y; Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, China.
  • Mou GZ; The First Hospital of Qiqihar, Qiqihar, China.
  • Li TZ; Molecular Medicine Research Center, School of Basic Medical Science, Chifeng University, Chifeng, China.
  • Xu WT; Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, China.
  • Zhang T; Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, China.
  • Xue H; Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, China.
  • Zuo WB; Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, China.
  • Li YN; Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, China.
  • Luo YH; Department of Grass Science, College of Animal Science & Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China.
  • Jin CH; Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, China.
Technol Cancer Res Treat ; 20: 15330338211004942, 2021.
Article em En | MEDLINE | ID: mdl-33759637
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Nivolumabe / Inibidores de Checkpoint Imunológico / Neoplasias Limite: Animals / Humans Idioma: En Revista: Technol Cancer Res Treat Assunto da revista: NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Nivolumabe / Inibidores de Checkpoint Imunológico / Neoplasias Limite: Animals / Humans Idioma: En Revista: Technol Cancer Res Treat Assunto da revista: NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos